https://www.pro.novartis.com/jp-ja/products/glivec/document 2025-09-12T04:16:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/glivec/material 2025-03-11T04:44:35+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/glivec/material/cml 2025-02-06T06:23:52+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/glivec/material/phall 2025-02-06T06:24:55+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/glivec/material/gist 2025-02-06T06:24:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/medical_video 2026-03-04T05:54:44+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta 2026-01-09T04:46:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_pnh 2025-12-25T08:16:17+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_pnh/pnh_movie 2026-01-09T04:48:22+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/material 2025-09-12T04:07:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/moa 2026-01-13T01:30:12+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/document 2026-03-31T01:41:42+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/point_04 2026-01-15T00:15:55+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/point_03 2026-01-15T00:15:58+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/clinical 2026-01-13T01:29:20+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/behavior 2026-01-15T00:16:01+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/inspection 2026-02-20T09:01:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/disease 2026-02-20T08:50:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/guideline_child 2026-02-20T08:54:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/guideline 2026-02-20T08:52:28+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/femara 2025-07-11T07:54:31+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/ic_child 2026-02-20T08:58:31+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/femara/document 2025-09-11T02:09:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/ic 2026-02-20T08:56:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/capacity 2026-02-20T08:13:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/moa 2026-02-20T09:07:42+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/clinical_child_02 2026-02-20T08:48:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fluorescite 2025-10-08T00:39:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/clinical_child_01 2026-02-20T08:46:22+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/clinical_03 2026-02-20T08:42:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fluorescite/document 2026-03-25T06:36:00+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/clinical_02 2026-02-20T08:36:49+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu 2025-11-20T06:03:20+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/clinical_01 2026-02-20T08:34:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/behavior 2026-02-20T08:10:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/document 2026-02-16T00:32:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/touyo 2025-07-15T06:14:00+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/behavior 2025-11-20T05:37:57+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd 2025-07-15T03:02:50+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/feature 2026-02-05T06:31:52+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/usage 2026-03-02T13:53:11+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical 2026-03-02T13:57:52+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/gilenya/about/index_2 2025-09-12T02:51:40+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_01 2025-11-20T05:38:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_02 2025-10-27T05:12:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_03 2025-11-20T05:38:13+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_04 2025-11-20T06:39:24+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_05 2025-10-27T05:12:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_06 2025-07-15T04:14:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_07 2025-11-20T05:38:21+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_08 2025-11-20T05:38:24+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_09 2025-11-20T05:38:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dme 2025-07-15T02:52:47+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dme/feature 2026-02-05T06:32:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dme/usage 2026-03-02T13:58:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dme/clinical 2026-03-02T14:00:09+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dme/clinical_01 2026-03-02T14:01:02+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dme/clinical_02 2025-10-27T05:13:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dme/clinical_03 2025-10-27T05:13:09+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dme/clinical_04 2025-11-20T05:38:42+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dme/clinical_05 2025-10-27T05:13:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dme/clinical_06 2025-07-15T06:13:24+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/vegamox 2025-07-11T07:49:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/vegamox/document 2026-03-25T06:37:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/vegamox/material 2025-09-12T02:51:44+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/voltaren 2025-09-12T02:51:47+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/voltaren/document 2026-03-31T00:36:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/mayzent 2026-03-17T07:52:55+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/mayzent/document 2026-03-25T02:00:21+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/mayzent/feature 2026-01-19T06:13:48+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/mayzent/point 2025-10-17T02:06:20+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/mayzent/material 2025-10-17T02:06:23+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lysakare 2025-03-11T07:08:09+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lysakare/document 2026-02-02T00:26:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/riamet 2026-02-05T02:13:09+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/riamet/document 2025-09-26T00:24:21+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ritalin 2025-03-11T08:18:52+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ritalin/document 2025-09-11T08:16:56+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/luxturna 2025-03-11T07:08:06+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/luxturna/document 2026-03-25T06:38:13+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/luxturna/point 2026-01-20T05:41:31+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/luxturna/material 2025-09-12T02:51:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis 2026-02-05T01:45:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/document 2026-03-25T06:39:52+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/amd 2025-08-29T06:18:50+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/amd/feature 2025-08-28T07:21:50+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/amd/clinical 2025-08-28T07:21:42+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/amd/clinical_01 2025-08-28T07:21:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/amd/clinical_02 2026-02-04T01:50:22+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/amd/point 2026-03-02T14:12:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/rvo 2026-03-13T07:51:09+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/rvo/feature 2026-01-20T00:26:12+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/rvo/clinical 2026-03-02T14:24:28+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/rvo/point 2026-03-02T14:27:00+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/mcnv 2025-09-01T08:12:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/mcnv/feature 2025-08-29T06:19:13+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/mcnv/clinical 2026-03-02T14:19:18+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/mcnv/point 2026-03-02T14:21:21+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/dme 2025-08-29T06:19:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/dme/feature 2025-08-29T06:18:59+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/dme/clinical 2026-03-02T14:14:19+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/dme/point 2026-03-02T14:17:02+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/rop 2026-01-20T00:25:20+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/rop/feature 2026-01-15T07:34:08+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/safety/02 2025-12-25T00:22:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/cpms/01 2025-07-15T08:07:28+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/rop/clinical 2026-03-02T14:22:18+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/rop/point 2026-03-02T14:23:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/behavior 2025-08-29T06:18:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/cpms/02 2025-07-15T08:07:31+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/point 2026-02-04T01:50:24+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/cpms/03 2025-07-29T06:36:24+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/sideeffect 2026-01-19T06:08:14+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/cpms/05 2025-07-15T08:07:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/sideeffect/01 2026-01-19T06:08:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/cpms/06 2025-07-15T08:07:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/sideeffect/02 2026-01-19T06:08:06+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/sideeffect/03 2026-01-19T06:08:08+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/cpms/07 2025-07-15T08:07:40+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/sideeffect/04 2026-01-19T06:08:11+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/cpms/08 2025-09-11T08:24:23+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/patianttool 2026-01-16T05:08:15+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/cpms/08_11 2025-08-05T05:28:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/cpms/09 2025-07-16T07:19:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lucentis/patianttool/hayami 2026-01-16T05:08:23+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/point_04 2026-01-30T10:02:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera 2026-01-29T05:54:23+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/point_05 2026-01-30T10:01:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/document 2025-10-20T02:14:14+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/disease 2026-01-23T07:45:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/disease/01 2026-02-02T09:50:44+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/disease/02 2026-01-30T08:05:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/point_06 2026-01-30T10:04:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/diagnosis 2026-02-03T03:27:48+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/diagnosis/01 2026-02-02T09:49:36+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/diagnosis/02 2026-01-20T05:52:09+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/diagnosis/03 2026-01-20T05:52:18+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/diagnosis/04 2026-01-20T05:52:22+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/diagnosis/05 2026-02-03T03:26:42+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/diagnosis/06 2026-01-22T03:00:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/therapy 2026-01-29T05:54:23+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/therapy/01 2026-01-27T06:27:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/therapy/02 2026-01-29T05:54:21+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/behavior 2026-01-15T07:13:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/clinical 2026-01-16T05:42:01+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/clinical/01 2026-01-15T07:15:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/clinical/02 2026-01-15T07:16:39+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/clinical/03 2026-01-16T05:41:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/clinical/04 2026-01-16T05:41:58+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/point 2026-01-27T06:27:49+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/point/01 2026-02-05T01:50:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lutathera/material 2025-09-11T08:24:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/regitin 2025-07-11T07:52:35+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/regitin/document 2025-09-11T08:17:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio/ascvd/epidemiology 2026-02-05T02:45:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio/patients/profile 2026-02-05T03:03:50+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio/about/efficacy 2026-02-05T02:48:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio/about/safety 2026-02-05T02:49:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/crinicaltrial 2026-01-08T08:26:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/crinicaltrial-cl101 2026-02-04T01:57:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/crinicaltrial-lt101 2025-06-30T00:36:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/crinicaltrial-cl304 2026-02-04T01:58:09+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/scale 2026-04-03T00:38:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/library 2025-06-30T00:36:17+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/product/dlbcl 2026-03-02T14:06:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/product/ball 2026-02-18T00:33:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/product/fl 2026-03-02T14:07:59+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/moa/car_t 2026-02-18T00:33:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/moa/moa 2026-02-18T00:39:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/results/dlbcl_juliet 2026-02-17T03:26:14+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/results/dlbcl_safety 2026-02-17T03:26:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/results/ball_eliana 2026-02-17T03:26:10+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/results/ball_ensign 2026-02-17T03:26:12+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/results/fl_elara 2026-02-17T03:26:19+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/results/fl_safety 2026-02-17T03:26:21+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/treatment/flow 2026-02-17T03:26:28+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/treatment/targetpatient 2026-02-13T02:51:48+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/treatment/apheresis 2026-02-17T03:26:24+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/treatment/bridging 2026-02-17T03:26:26+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/treatment/ld 2026-02-03T03:35:06+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/treatment/lv 2026-02-03T03:37:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/treatment/followup_afteriv 2026-02-03T03:31:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/treatment/followup_after4wks 2026-02-17T03:26:31+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/requirement 2026-02-04T01:57:58+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/cellchain 2026-02-17T03:26:08+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_pnh/pnh_material 2026-01-09T04:47:05+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/07 2025-09-11T08:24:39+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/p_movie 2026-02-20T09:09:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/p_movie 2026-01-13T01:30:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/pollinosis/p_movie 2025-03-18T08:20:55+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/seminar/ondemand 2026-04-06T03:00:24+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/asthma/material 2026-03-13T02:52:05+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/pollinosis/material 2025-05-08T01:03:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/update_info/material_order 2025-09-11T08:19:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/disease/schedule_xol 2026-02-24T07:24:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/disease/guideline_xol 2026-02-24T07:22:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/disease/communication_xol 2026-02-24T07:17:13+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/voc 2025-09-19T01:10:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support 2026-01-22T01:12:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/08 2026-02-02T10:02:05+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/09 2026-02-02T10:05:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/10 2026-02-02T10:05:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/11 2026-02-02T10:03:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/12 2026-02-02T10:04:23+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/medicalallynetwork/introduction 2026-01-20T04:42:26+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/seminar/online 2026-04-03T10:06:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/voltaren/movie 2025-07-11T07:41:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dr-interview 2025-03-28T00:21:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dr-interview/dr_hirano 2025-03-28T00:21:24+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/requirement 2026-02-05T01:50:55+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/joint_finding/case010 2025-03-04T00:37:49+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/joint_finding/case010_answer_10 2025-03-04T00:37:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/14 2025-09-11T08:18:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/13 2025-09-11T08:18:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/joint_finding/case011 2026-01-08T05:45:47+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/15 2025-09-11T08:18:42+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/16 2025-09-11T08:17:22+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dr-interview/dr_hattori 2025-03-28T00:21:21+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/scemblix/material 2026-02-20T07:06:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio/document 2026-02-25T05:18:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/pnh 2025-04-22T07:47:35+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/flexterity 2026-04-03T00:38:09+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/azorga 2025-03-11T00:36:51+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/azorga/document 2026-03-25T06:24:26+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/atectura/document 2025-12-03T00:49:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/afinitor/document 2025-09-11T08:17:48+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris 2025-06-05T00:09:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/exelon_patch/document 2025-09-11T08:17:52+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lampren/document 2025-10-01T01:00:49+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/lampren 2025-03-11T07:08:02+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/azorga/material 2025-09-11T08:17:26+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/afinitor/bc/link 2025-12-05T06:28:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/hem_mailservice 2025-07-25T03:04:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/hem_mailservice/raredisease 2026-02-05T07:45:24+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/hem_mailservice/hematologists 2026-02-02T09:42:20+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/afinitor/tsc/link 2025-03-24T01:30:35+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/afinitor/material 2025-03-10T04:29:49+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/afinitor/material/bc 2025-02-03T08:15:02+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/fmf 2025-06-09T06:19:39+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/afinitor/material/rcc 2025-02-03T08:16:05+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/other/disease_info_movie 2025-06-05T04:33:15+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/sjia 2025-06-09T06:19:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/afinitor/material/net 2025-02-03T08:15:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/afinitor/material/tsc 2025-02-03T08:16:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/rheumatology 2025-07-15T04:41:28+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/cutaneous_immunology 2025-07-11T04:22:50+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/product 2025-08-22T03:38:49+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/moa 2025-08-22T03:49:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/results 2025-08-22T04:04:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kymriah/treatment 2025-08-22T04:41:06+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/dr-interview/dr_yoshikawa 2025-02-10T02:26:15+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/product 2025-06-30T00:36:40+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/moa 2025-06-30T00:36:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record 2026-03-31T05:09:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/entresto/material 2026-01-09T03:00:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/entresto/movie 2025-09-24T02:29:27+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/behavior 2025-06-24T00:42:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/clinical 2026-03-10T04:13:47+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/shiyou 2025-09-11T08:17:31+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/material 2025-09-11T08:17:35+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/aosd 2025-06-24T00:38:35+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/other 2025-06-05T00:45:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/faq 2026-03-02T13:20:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol 2026-01-30T10:10:08+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol_01 2026-01-30T10:13:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol_02 2026-01-30T10:12:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol_03 2026-01-30T10:11:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol_04 2026-01-30T10:10:49+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_qol_05 2026-01-30T10:18:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/faq 2026-02-09T11:14:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/voltaren/faq 2025-07-11T07:22:50+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/scemblix/faq 2025-09-10T00:37:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/tafmek/tafinlar_faq 2025-04-25T00:20:12+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/jakavi/faq 2025-07-11T07:23:47+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/sandostatin/faq 2025-04-25T00:19:50+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio/faq 2025-04-25T00:20:00+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/sandimmun/faq 2026-03-02T14:28:17+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/neoral/faq 2025-09-12T07:09:34+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/tafmek/mekinist_faq 2025-04-25T00:20:39+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g 2026-04-06T07:03:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/revolade/faq 2025-07-11T07:22:11+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g/c3g_material 2026-04-06T07:03:11+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/entresto/faq 2026-02-09T14:51:31+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/clozaril/faq 2026-02-02T08:50:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide 2026-01-30T10:25:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_1 2026-01-30T10:13:56+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_2 2026-01-30T10:16:10+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_3 2026-01-30T10:18:05+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/azorga/faq 2026-02-02T08:47:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/azopt/faq 2026-01-30T10:41:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/vegamox/faq 2025-07-11T06:07:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/travatanz/faq 2025-06-17T00:03:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ilaris/faq 2026-03-02T13:00:30+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/faq 2025-07-11T06:23:14+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/atectura/faq 2026-01-30T10:39:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/enerzair/faq 2026-02-09T14:45:20+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ultibro/faq 2026-03-02T13:01:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/onbrez/faq 2026-03-02T13:15:18+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/seebri/faq 2025-07-01T13:01:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_5 2026-01-30T10:14:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_4 2026-01-30T10:15:14+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio/interview 2026-03-31T00:27:18+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/webinar-summary 2026-01-09T08:23:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/17 2025-07-07T06:15:58+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/18 2025-07-07T06:16:12+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/exelon_patch/faq 2026-03-02T12:58:52+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen 2026-03-26T07:34:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta-seminar-video 2026-01-30T10:23:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/package_updated_notice/2024 2026-03-25T07:04:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/lokametz_document 2025-12-23T02:01:28+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/galliapfarm_document 2025-12-23T01:57:49+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/tafmek/material 2026-03-10T07:03:59+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/web_reserve_introduction 2026-02-06T10:22:44+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/pluvicto_document 2026-03-19T00:29:00+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/pluvicto_faq 2025-10-28T07:51:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/ritalin/faq 2025-10-01T06:17:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/certican/faq 2026-01-08T07:24:19+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/19 2025-10-20T01:40:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/kesimpta_guide_6 2026-01-30T10:12:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/about_video 2026-03-26T07:19:39+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/rltcare 2025-11-27T04:26:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/plulocagagen/material 2026-03-19T00:37:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/understanding-symptoms 2026-02-20T00:47:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/patient-concerns 2026-02-20T00:41:56+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/patient-circumstances 2026-02-20T00:44:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/guideline_2018 2026-02-20T00:49:42+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/treatment-goals 2026-02-20T00:48:16+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr 2026-02-05T06:14:54+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/clinical 2026-03-02T14:02:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/treatment-goal 2026-02-20T00:50:21+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/today 2026-02-20T00:51:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_anti-cd20 2026-01-16T05:21:22+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_anti-cd20-01 2026-01-16T05:21:03+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_anti-cd20-02 2026-01-16T05:20:47+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_anti-cd20-03 2026-01-16T05:20:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zometa/faq 2025-12-02T05:49:55+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/patient-concerns-realities 2026-02-20T00:40:42+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/treatment-goals-challenges 2026-02-20T00:45:37+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/situation-assessment-communication 2026-02-20T00:49:07+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/xolair/urticarial/modern-treatment 2026-02-20T00:50:58+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/feature 2026-02-05T05:57:46+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/usage 2026-03-02T14:02:01+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_10 2026-02-05T04:55:58+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/clinical_01 2026-02-05T06:08:06+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/clinical_02 2026-02-05T06:09:28+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/pdr/clinical_03 2026-02-05T06:10:33+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_11 2026-02-05T04:57:57+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/beovu/amd/clinical_12 2026-02-05T04:59:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025 2026-01-08T00:08:57+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-01 2026-01-08T00:06:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-02 2026-01-08T00:06:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-03 2026-01-08T00:06:48+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-04 2026-01-08T00:07:04+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-05 2026-01-08T00:07:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-06 2026-01-08T00:07:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-07 2026-01-08T00:07:57+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/kesimpta/about/record_summit-2025-08 2026-01-08T00:08:32+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_pnh/pnh_behavior 2026-01-09T04:50:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_pnh/pnh_apply 2026-01-09T04:49:08+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_pnh/pnh_appoint 2026-01-09T04:50:14+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/20 2026-01-08T07:56:41+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/21 2026-01-08T07:57:29+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/alignment/22 2026-01-08T07:58:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/glivec/faq 2026-01-08T08:13:44+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g/c3g_disease 2026-04-06T06:59:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/fabhalta/disease_c3g/c3g_study 2026-04-06T06:59:53+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/hem_mailservice/interview_06 2026-02-13T00:37:23+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/support/lecture/hem_mailservice/interview_07 2026-02-13T00:35:12+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/package_updated_notice/2025 2026-03-25T06:58:25+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/discontinued_list/2025 2026-03-26T00:58:45+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/products/zolgensma/follow-up/ondemand 2026-04-06T03:00:38+00:00 hourly 0.5 https://www.pro.novartis.com/jp-ja/node/1 2026-03-10T00:21:08+00:00 daily 0.5 https://www.pro.novartis.com/jp-ja/node/46 2026-03-18T08:25:31+00:00 daily 0.5 https://www.pro.novartis.com/jp-ja/products/order 2026-04-06T00:18:02+00:00 daily 0.5 https://www.pro.novartis.com/jp-ja/products/leqvio 2026-02-25T05:40:21+00:00 daily 0.5 https://www.pro.novartis.com/jp-ja/sitemap.xml 2026-04-05T06:58:47+00:00